Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/179062
Title: | A Pan-cancer analysis reveals high-frequency genetic alterations in mediators of signaling by the tgf-β superfamily |
Author: | Korkut, Anil Zaidi, Sobia Kanchi, Rupa S. Rao, Shuyun Gough, Nancy R. Schultz, Andre Li, Xubin Lorenzi, Philip L. Berger, Ashton C. Robertson, Gordon Kwong, Lawrence N. Datto, Mike Roszik, Jason Ling, Shiyun Ravikumar, Visweswaran Manyam, Ganiraju Rao, Arvind Shelley, Simon Liu, Yuexin Ju, Zhenlin Hansel, Donna Velasco, Guillermo de Pennathur, Arjun Andersen, Jesper B. O'Rourke, Colm J. Ohshiro, Kazufumi Jogunoori, Wilma Nguyen, Bao-Ngoc Li, Shulin Osmanbeyoglu, Hatice U. Ajani, Jaffer A. Mani, Sendurai A. Houseman, Andres Wiznerowicz, Maciej Chen, Jian Gu, Shoujun Ma, Wencai Zhang, Jiexin Tong, Pan Cancer Genome Atlas Research Network |
Keywords: | Mutació (Biologia) Genètica Transducció de senyal cel·lular Factors de creixement Càncer Mutation (Biology) Genetics Cellular signal transduction Growth factors Cancer |
Issue Date: | 24-Oct-2018 |
Publisher: | Elsevier |
Abstract: | We present an integromic analysis of gene alterations that modulate transforming growth factor β (TGF-β)-Smad-mediated signaling in 9,125 tumor samples across 33 cancer types in The Cancer Genome Atlas (TCGA). Focusing on genes that encode mediators and regulators of TGF-β signaling, we found at least one genomic alteration (mutation, homozygous deletion, or amplification) in 39% of samples, with highest frequencies in gastrointestinal cancers. We identified mutation hotspots in genes that encode TGF-β ligands (BMP5), receptors (TGFBR2, AVCR2A, and BMPR2), and Smads (SMAD2 and SMAD4). Alterations in the TGF-β superfamily correlated positively with expression of metastasis-associated genes and with decreased survival. Correlation analyses showed the contributions of mutation, amplification, deletion, DNA methylation, and miRNA expression to transcriptional activity of TGF-β signaling in each cancer type. This study provides a broad molecular perspective relevant for future functional and therapeutic studies of the diverse cancer pathways mediated by the TGF-β superfamily. |
Note: | Versió postprint del document publicat a: https://www.cell.com/cell-systems/fulltext/S2405-4712(18)30357-0?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2405471218303570 |
It is part of: | Cell Systems, 2018, vol. 7, num. 4, p. 422-437.e7 |
URI: | http://hdl.handle.net/2445/179062 |
ISSN: | 2405-4712 |
Appears in Collections: | Articles publicats en revistes (Ciències Fisiològiques) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
687423.pdf | 10.91 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License